Purchase Order 12405B19P0513
- Not listed
- This federal contract award is for the procurement of a FLOW CELL, CAT#FLO-MIN 106/7 by the Southeast Area, a civilian agency within the U.S. government. The contract was awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, on August 15, 2018 for a total ceiling value of $116,016.00. The contract is a firm fixed-price purchase order with an ultimate completion date of August 23, 2019. The contract does not have a set-aside designation. Oxford...
- This is a $161,638 firm-fixed-price purchase order awarded by the Northeast Area division of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of ROSEN - Oxford Nanopore FLO-PRO002 Promethion Flow Cell Packs, which are consumable supplies for Oxford Nanopore's PromethION DNA/RNA sequencing platform. The contract has a completion date of September 14, 2022 and does not have a set-aside designation....
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, is for the delivery of 48 MinION Flow Cells (R10.4.1) and 12 Flongle Flow Cells (R10.4.1) to the USDA Agricultural Research Service Warmwater Aquaculture Research Unit in Stoneville, Mississippi. The award, valued at $23,760.00, is a firm-fixed-price purchase order with a completion date of April 26, 2024. The flow cells are proprietary, disposable components used in Oxford...
- This federal contract award, with ID AG4216P170059, was made by the U.S. government's Southeast Area agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $79,026.00 firm fixed-price purchase order is for the delivery of flow cells and sequencing kits. The award does not have a set-aside designation. Through this contract, Oxford Nanopore Technologies is supplying next-generation genomic sequencing equipment, consumables, and associated services to...
- Oxford Nanopore Technologies Inc. was awarded a $47,960 firm fixed-price purchase order by a civilian federal agency (Midwest Area) on December 6, 2019, for genomic sequencing consumables and reagents. The contract, which was set aside for total small business, called for the delivery of MinION flow cells (FLO-MIN 106D R9 and FLO-MIN 110 R10 models) and ligation sequencing kits (SQK-LSK109), with an ultimate completion date of December 20, 2019. The place of performance was Cambridge, MA, and...
- This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. government, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $14,475.00 contract is for the delivery of 24 flow cells to support an ongoing research project led by Dr. Chengfei Jiang. The award does not have a set-aside designation. Oxford Nanopore Technologies Inc. is an established federal contractor, holding several...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the delivery of RNA sequencing kits, ligation sequencing kits, rapid barcoding kits, and flow cells. The $70,000.00 firm-fixed-price purchase order was awarded by the Southeast Area office of a civilian federal agency. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts to provide...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of nanopore flow-cells and a ligation kit. The $19,227.99 firm fixed-price purchase order was awarded by the Northeast Area division of the U.S. Department of Agriculture's Agricultural Research Service. The contract has an ultimate completion date of May 10, 2024. Oxford Nanopore has secured multiple federal contracts and Indefinite Delivery Vehicles (IDVs)...
- Oxford Nanopore Technologies Inc. received a $95,605 firm fixed-price purchase order (Contract #GRD-CAPEX) from a civilian Southeast Area federal agency for genomic sequencing equipment and services, with performance in Cambridge, Massachusetts. The contract was awarded on September 5, 2019, with an ultimate completion date of October 4, 2019. This award was not associated with a small business set-aside designation. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology firm...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was made by the National Institute for Minority Health and Health Disparities, a civilian agency. The $16,500.00 firm fixed-price purchase order is for the delivery of OXFORD NANOPORE TECHNOLOGIES, INC.; FLOW CELL R9 4.1 products by December 31, 2023. This contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
Oxford Nanopore Technologies Inc. was awarded a $24.6K firm fixed-price purchase order by the Southeast Area civilian agency on September 27, 2019, for a bulk order of 48 flow cells (FLO-MIN106D R9.4 model). The contract, which is not associated with a set-aside designation, was completed by September 30, 2019, with performance occurring in Stoneville, Mississippi. Flow cells are consumable components essential to Oxford Nanopore's nanopore sequencing platforms, enabling researchers to conduct DNA and RNA analysis for genomic research applications. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in next-generation sequencing technologies, has established itself as a significant supplier to multiple U.S. federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, U.S. Department of Agriculture, Department of Defense, and Food and Drug Administration. The company's sequencing platforms and consumables support critical research initiatives across infectious disease tracking, agricultural genomics, and biomedical studies. The awardee's parent company, Oxford Nanopore Technologies PLC (United Kingdom-based), has also received direct federal awards, including COVID-19 detection contracts with the CDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 9/27/19 |